MAGNANI, CHIARA FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 3.578
EU - Europa 1.527
AS - Asia 1.432
SA - Sud America 214
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 6.785
Nazione #
US - Stati Uniti d'America 3.488
SG - Singapore 602
CN - Cina 361
IT - Italia 315
DE - Germania 234
HK - Hong Kong 214
RU - Federazione Russa 204
SE - Svezia 194
BR - Brasile 170
IE - Irlanda 156
VN - Vietnam 115
GB - Regno Unito 102
UA - Ucraina 76
CA - Canada 73
FR - Francia 47
FI - Finlandia 41
PL - Polonia 34
IN - India 31
NL - Olanda 25
BE - Belgio 22
AR - Argentina 21
ES - Italia 20
TR - Turchia 20
DK - Danimarca 17
ID - Indonesia 16
JP - Giappone 15
ZA - Sudafrica 15
KR - Corea 13
MX - Messico 13
BD - Bangladesh 11
CH - Svizzera 10
PK - Pakistan 7
AT - Austria 6
EC - Ecuador 5
EU - Europa 5
VE - Venezuela 5
AU - Australia 4
CO - Colombia 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HR - Croazia 3
IQ - Iraq 3
MY - Malesia 3
PA - Panama 3
PY - Paraguay 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
IL - Israele 2
MA - Marocco 2
MK - Macedonia 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BY - Bielorussia 1
CL - Cile 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 6.785
Città #
Ann Arbor 475
Ashburn 366
Singapore 300
Woodbridge 269
Chandler 251
Fairfield 236
Houston 211
Hong Kong 210
Wilmington 160
Frankfurt am Main 151
Dublin 150
Cambridge 101
Seattle 99
Milan 95
Dearborn 92
Jacksonville 87
New York 73
Santa Clara 71
Dallas 54
Los Angeles 54
Beijing 52
Princeton 49
Nanjing 43
Ho Chi Minh City 35
Shanghai 35
Hefei 32
Buffalo 25
Chicago 25
Lissone 24
Lawrence 22
Montreal 22
The Dalles 22
Brussels 21
São Paulo 19
Hanoi 18
Kraków 18
Denver 17
Lachine 16
Altamura 15
Brooklyn 14
Helsinki 14
Munich 14
Nanchang 14
Warsaw 14
Stockholm 13
London 12
Moscow 12
San Jose 12
Boardman 11
Jakarta 11
Johannesburg 11
Phoenix 11
Seoul 11
Tokyo 11
Fremont 10
Poplar 10
San Francisco 10
Amsterdam 9
Council Bluffs 9
Hangzhou 9
Jiaxing 9
Manchester 9
Orem 9
San Diego 9
Toronto 9
Dong Ket 8
Jinan 8
Pavia 8
Rome 8
Turku 8
Andover 7
Bergamo 7
Guangzhou 7
Hebei 7
Shenyang 7
Tampa 7
Zhengzhou 7
Atlanta 6
Boston 6
Curitiba 6
Genoa 6
Kunming 6
Taizhou 6
Zurich 6
Ankara 5
Belo Horizonte 5
Brescia 5
Columbus 5
Düsseldorf 5
Edmonton 5
Monza 5
Ningbo 5
Ottawa 5
Querétaro 5
Salt Lake City 5
Cagliari 4
Changsha 4
Chengdu 4
Chennai 4
Contursi 4
Totale 4.508
Nome #
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 374
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 356
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 353
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 310
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 309
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 300
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 298
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 297
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 283
Acute myeloid leukemia and novel biological treatments: Monoclonal antibodies and cell-based gene-modified immune effectors 263
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives 249
Acquired glucose sensitivity of k-ras transformed fibroblasts 245
Donor-derived CD19-targeted T cells in allogeneic transplants 243
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells 238
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor 237
Type 1 regulatory T cells: cytotoxic activity and molecular signature 233
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 227
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor 222
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells 220
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 206
Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells 205
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway 201
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 193
Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells 178
Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: A survey of different populations 178
The Past, Present, and Future of Non-Viral CAR T Cells 142
Low-Dose Lenalidomide Improves CAR-Based Immunotherapy In CLL By Reverting T-Cell Defects In Vivo 142
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 141
null 78
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance 43
Totale 6.964
Categoria #
all - tutte 21.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021313 0 0 0 0 0 0 48 55 48 70 33 59
2021/2022403 28 36 52 27 32 22 13 17 32 42 29 73
2022/2023792 89 229 105 71 40 112 9 44 59 4 24 6
2023/2024488 15 17 28 42 52 95 94 39 35 14 13 44
2024/20251.081 59 99 47 43 91 32 77 30 144 166 94 199
2025/20261.768 372 143 211 386 448 197 11 0 0 0 0 0
Totale 6.964